LCLAT1 and Parkinson disease: Ablation of ALCAT1 or pharmacological inhibition of ALCAT1 prevented the onset of MPTP‐induced neurotoxicity and locomotive defects, implicating a key role of the enzyme in the pathogenesis of PD.